ReviewCurrent opinion in hematology2026
Cryogenic electron microscopy and coagulation factors.
Review in Current opinion in hematology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
purpose of reviewCryogenic electron microscopy (cryo-EM) resolves the structures of proteins and their complexes under near-native conditions that are often inaccessible to other structural techniques. Cryo-EM has recently contributed significant advances in basic knowledge to the field of coagulation. New paradigms regarding individual domain role in protein-protein interactions have emerged, casting the main reactions of the coagulation cascade in a much-needed structural context. This review focuses on recent advances in the study of coagulation factors using cryo-EM. RECENT
findingsCryo-EM structures have defined the architecture of Factor V/Va free and bound to their biological partners, revealing that protease domains dominate protein-protein interactions while auxiliary domains act as scaffolds. Breakthroughs in mapping autoantibody epitopes for prothrombin and Factor VIII have elucidated pathogenic mechanisms in antiphospholipid syndrome and hemophilia. Furthermore, cryo-EM is accelerating biotherapeutic design, evidenced by recent structures of Factor XIIa, prothrombin and engineered Factor VIII. SUMMARY: Cryo-EM, often, enables the resolution of discrete macromolecular conformations using minimal quantities of full-length proteins. These structural insights enable the rational design of next-generation therapeutics and targeted diagnostics guided by near physiological forms, marking a new era in coagulation research. Future integration with HDX-MS, smFRET, and cryo-electron tomography (cryo-ET) will resolve these molecular machineries in situ on the surface of activated platelets and vascular beds.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.